Study summary

The purpose of this study is to compare Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT) stress myocardial perfusion imaging (MPI) with regadenoson in order to detect the presence or absence of reversible defects.

Additional Study Details

Phase
2
Product
N/A
Product
regadenoson
Type
Interventional
Masking
None (Open Label)
Enrollment number
124
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) using Multidetector Computed Tomography (MDCT) compared to Single Photon Emission Computed Tomography (SPECT)? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Oregon Health and Science University
    Portland, OR, United States, 97239
    Completed
    Maine Research Associates
    Auburn, ME, United States, 04210
    Withdrawn
    Heart Center Research LLC
    Huntsville, AL, United States, 35611
    Completed
    Henry Ford Health System
    Detroit, MI, United States, 48202
    Withdrawn
    Michigan Heart, PC
    Ypsilanti, MI, United States, 48197
    Withdrawn
    Santa Rosa Cardiology Medical Group, Inc.
    Santa Rosa, CA, United States, 95405
    Completed
    Midwest Cardiology Associates, P.C.
    Overland Park, KS, United States, 66029
    Completed
    Brigham and Women's Hospital
    Boston, MA, United States, 02115
    Withdrawn
    Alfieri Cardiology, P.A.
    Newark, DE, United States, 19713
    Completed
    Berkshire Medical Center
    Pittsfield, MA, United States, 01201
    Completed
    Baptist Hospital of Miami
    Miami, FL, United States, 33176
    Completed
    Harbor UCLA Medical Center
    Torrance, CA, United States, 90502
    Completed
    Sutter Roseville Medical Center
    Roseville, CA, United States, 95661
    Completed
    Cardiovascular Research Center of South Florida
    Miami, Florida, United States, 33173
    Withdrawn
    Medical University of South Carolina
    Charleston, SC, United States, 29401
    Completed
    Massachusetts General Hospital
    Boston, MA, United States, 02114

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?